Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Real-world Study of Efficacy and Safety of Penpulimab in Maintenance Therapy in Patients With Post-transplant or Transplant-intolerant Lymphoma

NCT05680038 is registered in ClinicalTrials.gov with WEI XU as lead sponsor.

NCT NCT05680038
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05680038 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Real-world Study of Efficacy and Safety of Penpulimab in Maintenance Therapy in Patients With Post-transplant or Transplant-intolerant Lymphoma
Lead sponsor
WEI XU
Phase
Observational
Overall status
Unknown status
Start date
March 1, 2023
Completion date
March 31, 2025
Enrollment
167 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

lymphoma